ClinVar Miner

Submissions for variant NM_000517.6(HBA2):c.1del (p.Met1fs)

dbSNP: rs587776828
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001811173 SCV001471734 pathogenic not provided 2020-01-30 criteria provided, single submitter clinical testing The HBA2 c.1delA; p.Met1? variant (rs33950507) is reported in the literature in multiple individuals affected with Hb H disease in trans to the --SEA deletion (Eng 2006, He 2017, Viprakasit 2014). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes a single nucleotide and abolishes the canonical initiation codon of HBA2, so it is predicted to result in an absent protein. Based on available information, this variant is considered to be pathogenic. References: Eng B et al. Three new alpha-thalassemia point mutations ascertained through newborn screening. Hemoglobin. 2006;30(2):149-53. He J et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017 Sep;19(9):1022-1031. Viprakasit V et al. Clinical presentation and molecular identification of four uncommon alpha globin variants in Thailand. Initiation codon mutation of a2-globin Gene (HBA2:c.1delA), donor splice site mutation of a1-globin gene (IVSI-1, HBA1:c.95 + 1G>A), hemoglobin Queens Park/Chao Pra Ya (HBA1:c.98T>A) and hemoglobin Westmead (HBA2:c.369C>G). Acta Haematol. 2014;131(2):88-94.
OMIM RCV000016985 SCV000037257 pathogenic Alpha-thalassemia, Hmong type 2006-01-01 no assertion criteria provided literature only
Natera, Inc. RCV001826474 SCV002093834 pathogenic alpha Thalassemia 2020-05-21 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.